Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
[
Type
]
Year
Filters:
Author
is
Kreutmair, Stefanie
[Clear All Filters]
Journal Article
Lysenko V
,
Schürch PM
,
Tuzlak S
,
van Wijk NWildner-Ve
,
Kovtonyuk LV
,
Becher B
,
Manz MG
,
Kreutmair S
,
Theocharides APA
.
Blocking the CD47-SIRPα interaction reverses the disease phenotype in a polycythemia vera mouse model.
Leukemia. 2023.
PubMed
Google Scholar
Illert AL
,
Seitz AK
,
Rummelt C
,
Kreutmair S
,
Engh RA
,
Goodstal S
,
Peschel C
,
Duyster J
,
von Bubnoff N
.
Inhibition of Aurora Kinase B Is Important for Biologic Activity of the Dual Inhibitors of BCR-ABL and Aurora Kinases R763/AS703569 and PHA-739358 in BCR-ABL Transformed Cells.
PLoS One. 2014;9(11):e112318.
PubMed
Google Scholar
Apostolova P
,
Kreutmair S
,
Toffalori C
,
Punta M
,
Unger S
,
Burk A-C
,
Wehr C
,
Maas-Bauer K
,
Melchinger W
,
Haring E
, et al.
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.
Br J Haematol. 2023.
PubMed
Google Scholar